Hualan Biological Engineering Inc.
SHZ: 002007.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bei Fan
- Employees
- 4,012
- Headquarters
- Xinxiang, China
- IPO year
- 2004
- Market cap
- CN¥26.6B
- Website
- https://www.hualanbio.com
Loading 002007…
Loading profile data…Frequently asked questions about 002007
What does Hualan Biological Engineering Inc. (002007.SZ) do?
Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin,...
Where does 002007.SZ trade?
Hualan Biological Engineering Inc. (002007.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002007.SZ in?
Hualan Biological Engineering Inc. (002007.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Hualan Biological Engineering Inc.?
Bei Fan is the chief executive officer of Hualan Biological Engineering Inc. (002007.SZ).
Where is Hualan Biological Engineering Inc. headquartered?
Hualan Biological Engineering Inc. is headquartered in China.
Does 002007.SZ pay a dividend?
Yes — Hualan Biological Engineering Inc. (002007.SZ) paid a trailing twelve-month dividend of CNY 0.70 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002007.SZ go public?
Hualan Biological Engineering Inc. (002007.SZ) completed its initial public offering in 2004.